0000904454-18-000629.txt : 20181002 0000904454-18-000629.hdr.sgml : 20181002 20181002185230 ACCESSION NUMBER: 0000904454-18-000629 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20181002 DATE AS OF CHANGE: 20181002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Forrester Robert CENTRAL INDEX KEY: 0001319890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35403 FILM NUMBER: 181103113 MAIL ADDRESS: STREET 1: C/O COMBINATORX, INCORPORATED STREET 2: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: (781) 292-4200 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-09-24 0001526119 Verastem, Inc. VSTM 0001319890 Forrester Robert C/O VERASTEM, INC. 117 KENDRICK STREET, SUITE 500 NEEDHAM MA 02494 1 1 0 0 President and CEO Common Stock 2018-09-28 4 P 0 2000 7.00 A 221234 D Common Stock 5000 I By trust Common Stock 5000 I By trust Stock Option (Right to Buy) 2.97 2018-09-24 4 A 0 60000 0 A 2018-09-24 2028-01-05 Common Stock 60000 60000 D Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 60,000 shares. /s/ Joseph Chiapponi, Attorney-in-Fact 2018-10-02